logo

For the Inventor, By the Inventor

Saline, MI, United States of America

Catherine R Kostlan

This inventor holds 41 USPTO granted patents and 1 published patent application, plus 1 CIPO patent, primarily in Anti-Inflammatory Compounds. Top assignees: Warner-Lambert Company, Basf Aktiengesellschaft, Graceway Pharmaceuticals, LLC. Active years: 1989-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Catherine R Kostlan. Retrieved from https://idiyas.com/inventor/catherine-r-kostlan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 41 

% Patents Active = 92.7


Average Co-Inventor Count = 3.0

ph-index = 9

Forward Citations = 248(Granted Patents)


Location History:

  • Ann Arbor, MI (US) (1989 - 1993)
  • Saline, MI (US) (1991 - 2013)

Company Filing History:

goldMedal38 out of 2,538 
 
Warner-Lambert Company
 patents
silverMedal2 out of 10,816 
 
Basf Aktiengesellschaft
 patents
bronzeMedal1 out of 7 
 
Graceway Pharmaceuticals, LLC
 patents
4. 1 out of 71 
 
Medicis Pharmaceutical Corporation
 patents
5. 1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1989-2013

Loading Chart...
Loading Chart...
Areas of Expertise:
Anti-Inflammatory
Pyrimidines
Oxadiazoles
Thiadiazoles
Biphenyl Compounds
Gout Treatment
Sebum Production
Cyclooxygenase
Angiotensin II Antagonists
Glutamic Acid Derivatives
Amino Compounds
Isoxazoles
41 patents (USPTO):Explore Patents
1. 8409595 - Method for decreasing sebum production (2013-04-02),
2. 7615230 - Method for decreasing sebum production (2009-11-10),
3. 6894057 - Oxo-azabicyclic compounds (2005-05-17),
4. 6316415 - Sulfonamide interleukin-1&bgr; converting enzyme inhibitors (2001-11-13),
5. 5932549 - N-substituted glutamic acid derivatives with interleukin-1.beta. (1999-08-03),
6. 5744451 - N-substituted glutamic acid derivatives with interleukin-1 .beta. (1998-04-28),
7. 5432181 - Substituted heteroaryl analogs of (1995-07-11),
8. 5376670 - 3,5-di-tertiary-butyl-4-hydroxyphenyl-1,3,4-thiadiazoles, and (1994-12-27),
9. 5356898 - Substituted 4,6-di-tertiary-butyl 5-hydroxy-pyrimidines (1994-10-18),
10. 5348957 - 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory (1994-09-20),
11. 5340815 - 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as (1994-08-23),
12. 5338737 - Biphenyl oxadiazoles and thiadiazoles as angiotensin II antagonists (1994-08-16),
13. 5312821 - 2-heterocyclic-5-hydroxy-1,3-pyrimidines useful as antiinflammatory (1994-05-17),
14. 5302597 - 2-substituted-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines useful as (1994-04-12),
15. 5284949 - 2-substituted amino-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines as (1994-02-08),

Title: Inventor Catherine R Kostlan - Pioneer in Innovation

Introduction: Catherine R Kostlan, a pioneering inventor based in Saline, MI (US), is known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Catherine R Kostlan holds several patents in various technological domains, including advancements in renewable energy systems, smart home devices, and medical technologies.

Career Highlights: With a career spanning over two decades, Catherine has worked with renowned research institutions and leading tech companies to develop cutting-edge solutions that have significantly impacted the industry.

Collaborations: Throughout her career, Catherine has collaborated with top engineers, scientists, and designers to bring her innovative ideas to life. Her ability to work in multidisciplinary teams has led to the successful implementation of several groundbreaking projects.

Conclusion: Catherine R Kostlan's relentless pursuit of innovation and her passion for creating technology that improves lives make her a true trailblazer in the world of inventors. Her work continues to inspire future generations of innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…